These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12638522)

  • 1. Grave's disease 1835-2002.
    Weetman AP
    Horm Res; 2003; 59 Suppl 1():114-8. PubMed ID: 12638522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.
    Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.
    Bufalo NE; Dos Santos RB; Marcello MA; Piai RP; Secolin R; Romaldini JH; Ward LS
    J Endocrinol Invest; 2015 May; 38(5):555-61. PubMed ID: 25543543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theories of causation of Graves' disease. A historical perspective.
    Sawin CT
    Endocrinol Metab Clin North Am; 1998 Mar; 27(1):63-72. PubMed ID: 9534028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
    van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
    Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.
    Prabhakar BS; Bahn RS; Smith TJ
    Endocr Rev; 2003 Dec; 24(6):802-35. PubMed ID: 14671007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Grave's and Basedow's thyroid associated ophthalmopathy--pathogenesis, symptoms and selected aspects of treatment].
    Nowak M; Kos-Kudła B
    Klin Oczna; 2000; 102(6):455-60. PubMed ID: 11392809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
    Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD
    J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
    Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
    Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients.
    van Steensel L; Hooijkaas H; Paridaens D; van den Bosch WA; Kuijpers RW; Drexhage HA; van Hagen PM; Dik WA
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E944-53. PubMed ID: 22438231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum immunoglobulin G4 levels and Graves' disease phenotype.
    Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
    Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
    Salvi M; Bingoye F; Chung F; Wall JR
    J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.
    Ginsberg J; von Westarp C
    CMAJ; 1986 May; 134(10):1141-7. PubMed ID: 2421862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin receptor autoantibodies recognizing two different epitopes on the TSH receptor: lack of relationship to patient age, sex, and ophthalmopathy.
    Jaume JC; Prummel MF; Wiersinga WM; McLachlan SM; Rapoport B
    Thyroid; 1993; 3(4):291-5. PubMed ID: 7509670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The eye changes of Graves' disease: overview.
    Werner SC
    Mayo Clin Proc; 1972 Dec; 47(12):969-74. PubMed ID: 4564711
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.